StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)

Close on Nov 17, 2026Market cap $1.97BP/E –Yield –

NeoGenomics gross margin

Gross margin is gross profit as a percentage of revenue.

NeoGenomics's gross margin for the twelve months ending Sep 30, 2026 was 44.8%. For fiscal 2025 it was 43.2%, against 43.9% the year before. The highest annual figure on record is 48.1% in fiscal 2019.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202543.2%−0.7
FY2024Dec 31, 202443.9%+2.6
FY2023Dec 31, 202341.3%+4.5
FY2022Dec 31, 202236.9%−1.8
FY2021Dec 31, 202138.6%−3.2
FY2020Dec 31, 202041.8%−6.3
FY2019Dec 31, 201948.1%+2.2
FY2018Dec 31, 201846.0%+3.5
FY2017Dec 31, 201742.4%+0.1
FY2016Dec 31, 201642.3%−1.5
FY2015Dec 31, 201543.8%−2.9
FY2014Dec 31, 201446.8%−1.0
FY2013Dec 31, 201347.7%+2.9
FY2012Dec 31, 201244.8%+0.1
FY2011Dec 31, 201144.7%−1.2
FY2010Dec 31, 201045.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202646.2%+3.3
Q2 FY2026Jun 30, 202645.6%+3.0
Q1 FY2026Mar 31, 202643.3%−0.3
Q4 FY2025Dec 31, 202543.8%−1.1
Q3 FY2025Sep 30, 202542.8%−1.8
Q2 FY2025Jun 30, 202542.6%−1.5
Q1 FY2025Mar 31, 202543.6%+1.7
Q4 FY2024Dec 31, 202444.9%+1.5
Q3 FY2024Sep 30, 202444.6%+3.6
Q2 FY2024Jun 30, 202444.1%+3.3
Q1 FY2024Mar 31, 202441.9%+2.0
Q4 FY2023Dec 31, 202343.5%+2.5
Q3 FY2023Sep 30, 202341.0%+3.0
Q2 FY2023Jun 30, 202340.8%+5.6
Q1 FY2023Mar 31, 202339.9%+7.3
Q4 FY2022Dec 31, 202241.0%+5.0
Q3 FY2022Sep 30, 202238.0%−1.0
Q2 FY2022Jun 30, 202235.1%−8.4
Q1 FY2022Mar 31, 202232.6%−3.4
Q4 FY2021Dec 31, 202136.0%−9.6
Q3 FY2021Sep 30, 202138.9%−4.2
Q2 FY2021Jun 30, 202143.5%+11.3
Q1 FY2021Mar 31, 202136.0%−7.7
Q4 FY2020Dec 31, 202045.6%−1.1
Q3 FY2020Sep 30, 202043.1%−5.5
Q2 FY2020Jun 30, 202032.2%−15.9
Q1 FY2020Mar 31, 202043.7%−5.6
Q4 FY2019Dec 31, 201946.7%−1.8
Q3 FY2019Sep 30, 201948.6%+1.8
Q2 FY2019Jun 30, 201948.1%+3.1
Q1 FY2019Mar 31, 201949.3%+6.2
Q4 FY2018Dec 31, 201848.5%+5.0
Q3 FY2018Sep 30, 201846.8%+4.7
Q2 FY2018Jun 30, 201845.1%+1.1
Q1 FY2018Mar 31, 201843.0%+3.1
Q4 FY2017Dec 31, 201743.6%−1.5
Q3 FY2017Sep 30, 201742.1%–
Q2 FY2017Jun 30, 201743.9%–
Q1 FY2017Mar 31, 201740.0%–
Q4 FY2016Dec 31, 201645.1%–

More NeoGenomics figures

See a number that looks wrong?